A pilot study of the feasibility of long-term human bone balance during perimenopause using a 41Ca tracer

TLDR: A pilot long-term feasibility study of bone health is explored by measuring the 41 Ca trace element in urine for six years from premenopausal to later perimenopausal phases in one midlife woman and measuring bone mineral density in parallel.

Abstract: The mechanisms governing calcium fluxes during bone remodeling processes in perimenopausal women are poorly known. Despite higher, albeit erratic, estradiol levels in perimenopause, spine bone loss is greater than during the first five years past the final menstrual flow when estradiol becomes low. Understanding changes during this dynamic transition are important to prevent fragility fractures in midlife and older women. The exploration of long-lived 41 Ca ( T 1/2  = 1.04 × 10 5  yrs) tracer measurements using accelerator mass spectrometry (AMS) leads to the possibility of monitoring bone remodeling balance. With this new technology, we explored a pilot long-term feasibility study of bone health by measuring the 41 Ca trace element in urine for six years from premenopausal to later perimenopausal phases in one midlife woman. We measured bone mineral density in parallel.